Back to home » Archives » POZ Magazine issues |
|
|
December 2012
Features
Love is the Cure
by Sir Elton John
When it comes to the fight against HIV, the founder of the Elton John AIDS Foundation believes we need allies, not enemies.
|
From the Editor
More Than a Feeling
by Oriol R. Gutierrez Jr.
As an openly HIV-positive gay Latino, I know how difficult it can be to come out and to live your life with dignity and hope.
|
Feedback
The POZ Q+A
Towards an HIV Cure
by Oriol R. Gutierrez Jr.
Researcher and clinician Steven G. Deeks, MD, explains the cure science and gives us reasons for hope.
|
POZ Planet
A Very Big Kiki
by Trenton Straube
Vogueing is still in fashion—and so is HIV prevention. Both shared the runway at the Gay Men’s Health Crisis (GMHC) annual House of Latex Ball.
|
Russians Deploy 'Google Bombs'
by Trenton Straube
When the Russian Ministry of Health failed to procure HIV meds for its citizens, Alexandra Volgina “Google bombed” the ministry.
|
Home Alone
by Trenton Straube
Over-the-counter HIV tests: helpful or harmful?
|
Back to School
by Trenton Straube
A roundup of sexual education in the news.
|
What's a Buyers' Club? Matthew Knows.
by Trenton Straube
Matthew McConaughey has morphed from studly stripper to scary skinny to play real-life Texan Ron Woodroof, the rebellious figure who started The Dallas Buyer’s Club (also the film’s title) and who died of AIDS in 1992.
|
Voices
Tried and True
The support of family and friends is indispensable for all of us, but it’s especially so for people with HIV/AIDS, who often deal with rejection, stigma and discrimination.
|
Care and Treatment
One a Day to Keep Heart Attacks Away?
by Tim Horn
Aspirin. It’s inexpensive, widely available and may reduce the risk of heart attacks and strokes among people living with HIV, but it’s not being used by many of those who might benefit, according to two new studies.
|
One Form to Rule Them All
by Tim Horn
For uninsured HIV-positive people with low incomes, applying for free or discounted HIV meds just got a little bit easier.
|
Stribild is Here
by Tim Horn
Formerly known as the Quad, the single-tablet regimen Stribild was approved in late August and landed on pharmacy shelves soon thereafter.
|
T-Totaller
by Tim Horn
Hypogonadism, or low T, is common in men with the virus and can cause problems like fatigue, depression and bone loss.
|
Nature's Little Helpers
by Tim Horn
A group of plant chemicals is being eyed by Johns Hopkins University (JHU) researchers for its ability to protect brain function in people living with HIV.
|
Research Notes
Treatment: Dolutegravir Shows Promise
by Tim Horn
Dolutegravir, the once-daily integrase inhibitor that doesn’t require boosting, continues to leave a trail of encouraging news on its path to approval.
|
Concerns: Fewer Comebacks From Heart Attacks
by Tim Horn
HIV-positive people who experience a heart attack and require hospitalization are more likely to die, compared with those not living with the virus, say the sobering results of a U.S. data analysis.
|
POZ Survey Says
Healthy Technology
by Jennifer Morton
Mobile and digital information technology can help health care providers and patients in many ways.
|
POZ Heroes
|
|
|
 |
|
